Product
Anti-CD25 mAb
1 clinical trial
1 indication
Indication
Graft-Vs-Host DiseaseClinical trial
Efficacy and Safety of UC-MSCS for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT: A Multicenter, Randomized, Open-label TrialStatus: Completed, Estimated PCD: 2022-05-30